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ABSTRACT 
Low dimensional semiconductor quantum dots (<10 nm) have received great attention for 
potential use in biomedical applications (diagnosis and therapy) for which larger nanoparticles 
(>10 nm) are not suitable. Here, we demonstrate a green, biogenic synthesis route for making 
CdS quantum dots (QDs) with 2-5 nm particle size using tea leaf extract (Camellia sinensis) as 
a toxic-free particle stabilizing agent. We have explored the biological activity of these CdS 
QDs in different applications, namely; a) antibacterial activity b) bioimaging and c) apoptosis 
of lung cancer cells. The antibacterial activity of the CdS QDs has been studied against different 
types of bacteria growth, showing that CdS QDs effectively inhibit the bacterial growth and 
exhibit cytotoxicity towards A549 cancer cells when compared to a control (no QD treatment). 
We have compared this cytotoxicity effect on A549 cancer cells with a standard drug, cisplatin, 
showing comparable results. Additionally, these CdS QDs produce high contrast fluorescence 
images of A549 cancer cells indicating a strong interaction with the cancer cell. To further 
understand the role of CdS QDs in bioimaging and cytotoxicity effect in A549 cells, 
fluorescence emission and flow cytometry analysis were carried out. The fluorescence 
emission of CdS QDs were recorded with λexc= 410 nm, showing concentration dependence 
fluorescence emission centered at 670 nm.  From the flow cytometry analysis, it is confirmed 
that the CdS QDs are arresting the A549 cell growth at the S phase of cell cycle, inhibiting 
further growth of lung cancer cell. The multifunctional advantages of Camellia sinensis extract 
mediated green CdS QDs will be of widespread interest in implementing in-vivo based 
bioimaging and therapeutic cancer treatment applications.    
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Introduction 
Low dimensional semiconductor nanoparticles and/or quantum dots (QDs) have received 
great attention in cancer treatment nanotechnology. For instance, as-synthesized or modified 
nanoparticles are widely applied in tumor imaging, drug delivery1,2 and diagnosis and treatment 
of cancer3,4. In this context, low dimensional nanomaterials based nano-formulated drugs are 
promising candidates to treat disease via targeted drug delivery5,6. Targeted drug delivery based 
biological treatment is highly precise and prevents side effects originating from systemic 
distribution of cytotoxic drugs and effectively controls cancer cell proliferation or tumor 
angiogenesis7-8.  
Recent reports show that metal based nanoparticles can efficiently destroy cancerous cells 9, 
10, 11, 12. In particular quantum dots (QDs), show superior production of reactive oxygen species 
(ROS) in biological systems 10, 13, 14. In addition, QDs have other advantages including; typical 
sizes of <10 nm, exceptional physicochemical properties, low cytotoxicity and bio-
compatibility. Thus, semiconductor QDs have found use in a number of biomedical 
applications, including bio-imaging, bio-sensing and drug delivery 15, 16, 17, 18, 19, 20, 21,22  
CdS QDs have been identified as a potential candidate to diagnose cancerous cells.23 CdS 
QDs have been synthesized through a broad range of physical and chemical techniques such as 
microwave heating, micro emulsion synthesis and ultrasonic irradiation 24, 25. However, for 
highly precise detection of cancer cells, CdS QDs made from standard chemical synthesis is 
complicated and expensive, requiring hazardous chemicals and multiple synthetic steps26. 
Therefore, alternative approaches are needed which allow synthesis using non-hazardous 
materials, whilst maintaining the important properties of size, physicochemical properties, low 
cytotoxicity and bio-compatibility. In this context, nanoparticles made via biogenic synthesis 
using bio-surfactants (microbes and plants) are a promising approach. Also, it offers precise 
control of the particle size distribution and homogeneity through a slow rate of chemical 
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reaction.27 Compared to conventional chemical based particle stabilizers, plant extract based 
surfactants exhibit many advantages such as biodegradability, biocompatibility and low-
toxicity28, 29, 30, 10 . Borovaya et al 31 reported Nicotinum tabaccum act as a biological source 
for quantum dots synthesis to produce biocompatible QDs. In addition, microorganisms such 
as bacteria, fungi and yeast have also been studied for biogenic synthesis of nanomaterials. For 
instance, Bacilllus licheniformis is a microbial source for synthesis of gold nanotubes 32. 
Moreover, there have been a few studies of water soluble QDs which have been reported but 
they have needed expensive precursors for their production33. Galeone et al 34 demonstrated 
different polymer coated CdS quantum dots showing appreciable biocompatibility. Recent 
reports on CdS QDs derived from biogenic synthesis 35 show excellent quantum confinement 
effect 36, high luminescence emission 31, 37 and excellent antimicrobial activity38. One of the 
main advantages of biogenic synthesis approach is that organic biomolecules from plant 
extracts are involved as a stabilizing agent to control the particle size of the CdS QDs which 
does not induce any significant damage to the cells 24, 31.  Recent studies on Asparagus 
racemosus extract mediated CdS quantum dots showed less DNA damage activity 39. This 
highlights that plant extract mediated CdS QDs can be biocompatible, less toxic and cost 
effective and thus highly promising for in vitro studies.   
In this context, we have derived CdS QDs using tea leaf (Camellia sinensis) extract as 
particle stabilizing agents. Tea leaves contain polyphenols, amino acids, caffeine, vitamins, 
minerals and antioxidants. It is anticipated that chemical constituents of Camellia sinensis plays 
a key role in the formation of CdS QDs. For the first time, we demonstrate the biological 
activity (antibacterial, intracellular fluorescence mapping, apoptosis effect on A549 cells) of 
Camellia sinensis derived CdS QDs. This work highlights the synthesis of low dimensional 
green semiconductor QDs and explores the inter-relationship between material property and 
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biological activity (antibacterial, hemolytic activity and anticancer activity in lung cancer 
cells). The results were compared with control samples and commercial products.   
 
EXPERIMENTAL SECTION 
Materials: Cadmium sulfate (CdSO4, 99.99% purity) and sodium sulfide (Na2S, 98 % purity) 
were obtained from sigma Aldrich, USA. All other reagents were used in analytical grade. 
Deionized water used throughout experiment obtained from ultra-pure water purification 
system.  
Preparation of plant extract: The Camellia sinensis plant leaves were obtained from Valparai 
(Tamil Nadu, India) location. First, the leaves were washed with distilled water and then dried 
under shade. Followed that 3 g of chopped leaves were taken, with 30 mL of methanol and 
kept at 24 h incubation. Then the extract solution was filtered through the Whatman qualitative 
filter paper (grade number 1) and stored at 4 ̊C for further use.  
Green synthesis of CdS quantum dots: The CdS QDs were prepared in two stages. In first 
stage 2 mL of 0.025 M CdSO4 was added to 30 mL of Camellia sinensis extract and kept for 3 
days incubation in the dark. In the second stage, 0.5 mL of 0.025 M Na2S was added and 
incubated for another 4 days to produce CdS nanoparticles. The resultant final solution was in 
bright yellow colour and was centrifuged at 13,000 rpm for 10 minutes. In order to remove the 
contamination in the recovered CdS QDs, the solid was washed with deionized water and 
repeated three times. Finally, the pellet was lyophilized for further characterization studies. The 
experimental stages of CdS QDs is illustrated in Scheme 1.  
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Scheme 1. Illustration of experimental stages involved in Camellia sinensis extract mediated 
green CdS QDs synthesis. 
Measurements and analysis: The surface morphology and elemental analysis of resultant CdS 
solid sample was recorded using scanning electron microscope SEM (JEOL JSM 6360, Japan) 
coupled with EDX (Oxford instrument, INCApentaFETx3, England). Further, shape, and 
crystalline nature of the resultant CdS solid sample was studied using high resolution 
transmission electron microscopy (HRTEM) (JEOL JEM 2100, Japan). In order to understand 
the influence of organic species presence in the plant extract on CdS the FTIR spectra was 
recorded with a resolution of 1 cm-1 in the transmittance mode and 100 mg of potassium 
bromide (KBr) used as a reference (IR prestige 21, Shimadzu). The UV-Vis absorption and 
fluorescence emission spectra were performed on a Perkin Elmer Lambda 9 and a Horiba 
FluoroMax-4, respectively. The excitation wavelength was selected via monochromator and 
no filter was added on the pathway. For optical measurements, the CdS QDs were dispersed in 
ethanol and DMSO solvent.  
Biological studies: 
 Antibacterial activity: Antibacterial activity of CdS QDs is studied by well diffusion method 
against Escherichia coli, Serratia marcescens, Streptococcus pyogens, Staphylococcus aureus 
and Klebsiella pneumoniae. The clinical pathogenic cultures were inoculated in nutrient broth 
and incubated for overnight at shaking incubator (37 ̊C). The overnight grown bacterial culture 
was swabbed on Muller Hinton agar with sterile cotton swabs. A 5 mm diameter of well was 
made on agar plates. In these wells, different concentrations of CdS QDs (40, 80, 120, 160 and 
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200 µg/mL) were loaded and incubated for 24 hours. After incubation period, the zone of 
inhibition was measured with millimeter ruler. 
Hemolysis activity:  The process of hemolysis was used for determining toxic effect of the 
drug with RBC cells. Healthy human blood sample was freshly harvested and PBS (phosphate 
buffer saline, pH 7.4) was added at 1:2 volume ratio. Further, it was centrifuged at 10,000 rpm 
for 15 minutes. Finally, RBCs (red blood cells) were isolated by removing the supernatant. In 
order to remove erythrocytes from the RBCs it washed with sterile PBS for five times. The 
resultant RBC cells were diluted with 40mL of PBS. Then 0.2 mL of RBC cells at different 
concentrations of CdS QDs (10, 20, 30, 40, 50 and 60 µg/mL) were mixed to RBC cells in 
vortex. These samples were incubated at room temperature (24 ̊C) for 3 hours. Then 
centrifuged at 10,000 rpm for 2 minutes, the supernatant was finally taken out for recording 
optical absorbance analysis at 541 nm40 wavelength. The percentage of hemolysis was 
estimated using the relation 
𝐻𝑒𝑚𝑜𝑙𝑦𝑠𝑖𝑠 =
𝑆𝑎𝑚𝑝𝑙𝑒  𝐴𝑏𝑠−𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝐶𝑜𝑛𝑡𝑟𝑜𝑙
𝑃𝑜𝑠𝑡𝑖𝑣𝑒 𝐶𝑜𝑛𝑡𝑟𝑜𝑙−𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝐶𝑜𝑛𝑡𝑟𝑜𝑙
× 100   (1) 
Note that the RBC cells were incubated with water and PBS for positive and negative controls, 
respectively. 
Cytotoxic activity: The cytotoxic effect of the resultant CdS QDs solid sample was treated 
with A549 cells by MTT assay. To evaluate the efficiency of CdS QDs samples, a similar 
cytotoxic protocol was carried out using cisplatin (standard drug).  The human lung alveolar 
basal epithelial cell line (A549) was purchased from the National Centre for Cell Sciences 
(NCCS), Pune, India and cells were maintained in DMEM (Dulbecco’s Modified Eagle media) 
medium with nonessential amino acids. The cells were maintained at 37 ̊C with 5% of CO2 
incubator until the growth attained 90 % confluence and cells were seeded in a 96 well plate at 
a density of 4×103 cells/well. For comparative cytotoxicity analysis, the A549 cells were treated 
with different concentrations of CdS QDs and standard drug cisplatin (10, 20, 30, 40 and 50 
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µg/mL) which incubated for 24 hr. For MTT assay analysis, 100 µl of MTT- (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was added with above mentioned CdS 
QDs as well as cisplatin drug treated cells and kept for 4hr incubation. Then finally 100 µl of 
dimethyl sulphoxide (DMSO) was added which resulted in purple colour formazon crystals. 
The plates were read at 620 nm in a multi well plate reader (Biorad) and the percentage of cell 
viability is calculated by using the formula.41 
Percentage of viability =
Absorbance of treated cells (CdS QDs)
Absorbance of control cells (untreated)
×100  (2) 
In order to ensure morphological change in A549 cells under different concentrations of CdS 
QDs treatment (10, 25 and 50 µg/mL), the treated samples were grown on coverslips (1×105 
cells per coverslip) and incubated for 24 h. Following the incubation, the samples were fixed 
with methanol: acetic acid solution (3:1, v/v). The resultant A549 cells grown coverslip was 
gently mounted on the glass slide and morphological change were recorded using a bright field 
microscope (Nikon, Japan) at 40x magnification. 
Apoptosis Assessment:  A549 cells was seeded in a six well plate and treated with different 
concentrations of CdS QDs (10, 25 and 50 µg/mL) for 24 hours. Then these cells were washed 
with phosphate buffered saline (PBS - pH 7.2) and finally stained with AO/EtBr [100 mg/mL 
of acridine orange (AO) and 100 mg/mL of ethidium bromide (EtBr) in deionized water. After 
the cells were kept at 3 minute incubation, it was visualized under fluorescence microscope 
(Nikon Eclipse, Inc, Japan) at 40x magnification with an excitation filter at 480 nm. The similar 
procedure was followed for DAPI (4',6-diamidino-2-phenylindole).42  
Cell cycle analysis by flow cytometry: A549 cells (1x105) were seeded in a six well plate. 
After 24 h incubation at 37˚C (5% of CO2), it was changed to fresh medium and supplemented 
with the CdS QDs (10, 25 and 50 µg/mL). After 24-h incubation, the untreated and CdS QDs 
treated A549 cells were harvested with trypsin. Then these samples were washed by PBS and 
fixed in 70% of ethanol and stored at -20˚C for 1h.  The cellular nuclear DNA was stained with 
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propidium iodide (PI) and removing the ethanol content through PBS washing. Then cells were 
suspended with 0.5 mL PBS containing 50 µg/mL of PI and 100 µg/mL RNase were added and 
kept incubation at 37˚C for 30 min. Flow cytometry was performed in duplicate with a BD 
FACS flow cytometer (USA). From each sample 10,000 events were collected. The fluorescent 
signal intensity was recorded and analyzed by CellQuest and Modifit. 
Apoptotic analysis of A549 cells:  The apoptotic effect of CdS quantum dots at A549 
cells (1×105 cells/mL) was studied through annexin V-FITC and propidium iodide dual 
staining flow cytometry method. After incubation period, QDs treated A549 cells were 
harvested, and washed with PBS. Then finally treated with Trypsin/EDTA solution and 
suspended cells were centrifuged at 2000 rpm for 10 mins. In the cell pellet, above 
mentioned 100 µl of annexin V-FITC (Strong Biotech Co., Taipei, Taiwan) staining 
solution was added and incubated for 15 minutes at 25 ̊C. These cells were then analyzed 
with a flow cytometer (FACS verse, BD Bioscience, USA). 
Statistical analysis: All the in vitro experiments were carried out in triplicate and the 
experiments repeated at least three times. Statistical analysis was performed by one-way 
ANOVA (GraphPad Prism 5.0 software), followed with Bonferroni test for multiple 
comparisons. Statistical evaluation is performed using the results from a mean standard 
deviation of three experiments in each batch.  
 
RESULTS AND DISCUSSION 
Structural analysis: Figure 1 (a) and (b) show the surface morphology and composition 
analysis of the as-synthesized CdS sample. From Figure 1a, SEM image depicts smooth and 
spherical morphology of the CdS particles. The strong peaks from energy dispersion spectra 
(EDS) corresponding to Cd and S indicating the formation of cadmium sulfide (Figure 1b). 
The additional oxygen peak presence in the EDS spectra might originate from organic capping 
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material bound on the surface.  The similar observation on presence of oxygen species from 
biosynthesized CdS using Chlamydomonas reinhardtii is reported in the literature.43 
Furthermore, the shape and particle size of the CdS particles were studied by HRTEM. Figure 
1c demonstrates that the CdS particles are homogeneously distributed in the range from 3-5 
nm.  
 
 
Figure 1. (a) SEM image of CdS QDs; (b) EDAX spectrum of CdS QDs; HR-TEM image of 
synthesized CdS QDs (c) at 20 nm scale and (d) high magnification at 5 nm scale.   
Average particle size estimated from TEM is 3 ±1 nm and thus are considered as quantum 
dots (<10 nm). In few places QD agglomeration is evident due to the high concentration of 
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sample loaded on the copper grid for HRTEM analysis.44 In literature, different QD sizes have 
been  reported (from 4- 10 nm), for instance, 5-10 nm CdS nanoparticles was achieved using 
Fusarium biomass.45 Borovaya 46 et al. demonstrated Pleurotus ostreatus derived CdS QDs of 
size 4–7 nm.  Comparing these reports, the present result of 3-5 nm CdS QDs implies that 
Camellia sinensis extract is highly effective in forming small QDs. In biomass (algae and 
fungus) based biogenic synthesis, the resultant nanoparticle shape and size distribution is often 
a challenge and not homogenous. In the case of plant extract based biogenic synthesis, 
generally, highly stable and homogenous shaped nanoparticles are formed. The high resolution 
HRTEM image at 5 nm scale (Figure 1d) clearly demonstrates the lattice fringe of CdS QDs. 
The average lattice diameters between two fringes were found to be 0.33 nm. This implies that 
the resultant CdS quantum dots belong to (111) cubic crystalline structure of CdS. The 
existence of (111) crystalline phase was confirmed by X-ray diffraction spectra (Figure S1 in 
supporting information). Furthermore, a thin shell layer is observed on the CdS QDs (Figure 
S2, supporting information) which may be attributed to the organic moieties from the tea leaf 
extract. This is in line with observed oxygen content from EDAX spectra (Figure 1b). 
In order to decipher the role of the tea leaf extract in CdS QDs synthesis and observed shell 
layers on the CdS QDs (Figure S2), the FTIR spectra was recorded (See supporting 
information Figure S3). Figure S3(a) exhibits multiple absorption peaks that belong to various 
functional groups presence in the Camellia sinensis extract. The peak located around 3441 cm-
1 can be assigned to the involvement of O-H (alcohol). In the region around 3500 cm-1 due to 
N-H stretching vibration bands of the plant extracts may overlap with the carboxyl band47. The 
significant peak observed at 1649 cm-1 (due to stretching of C=O) corresponds to the amide 
groups (polyphenols, proteins and amino acids). The remaining major peak at 1007 cm-1 could 
be attributed to aliphatic amines.48 The FTIR features of Camellia sinensis extract mediated 
CdS is presented in Figure S3 (b). Compared to Figure S3 (a), a weak peak observed around 
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630 cm-1 indicates the CdS formation.49 In addition, significant differences were observed 
between plant extract (Camellia sinensis) and sythesized CdS QDs. Importantly, the peaks 
appeared at 3421, 1633 and 1376 cm-1 corresponding to the O-H (carboxyl group), C=O (amide 
group: polyphenols, proteins and aminoacids) and N-H bending vibrations of amide-II, 
respectively imply that the organic residue of Camellia sinensis may have immobilized on the 
surface of CdS nanoparticles.  It is anticipated that one of these constituents is involved in the 
biotransformation based particle size reduction and capping on the CdS QDs.50  In silver (Ag) 
nanoparticle synthesis, Sun et al. noticed that polyphenols components from Camellia sinensis 
extract were involved in the reduction of Ag+ ions into Ag nanoparticles51. Few other 
researchers have also experienced a similar type of biotransformation based nanoparticle 
synthesis 52, 53. We speculate that proteins binders in the Camellia sinensis may play a key role 
in CdS particle size reduction through amine groups or cysteine residues. A similar observation 
has been noticed by Rao et al.43 using Chlamydomonas reinhardtii extract based biogenic 
synthesis. Chlamydomonas reinhardtii contains proteins, amino acids and oxidoreductase 
enzymes, where these enzymes are responsible for biotransformation of CdS nanoparticles.54, 
55 Also, we believe that polyphenols, proteins, caffeine, catechins, theaflavins, thearubigins and 
aminoacids presence in the Camellia sinensis extract may response to the nanosize CdS QDs 
formation.  Based on the above explanation, the plausible mechanism for CdS QDs formation 
is explained in Scheme 1. While CdSO4 is added to plant extracts, Cd
2+ ions bind with the plant 
mediated proteins due to metallic stress. During the addition of Na2S, it facilitates in the 
formation of S2- ions that bind to the plant mediated cadmium proteins and results in the 
synthesis of CdS nanoparticles.  
Antibacterial activity of nanoparticles: The antibacterial activity of plant mediated CdS QDs 
nanoparticles against gram positive (Streptococcus pyogens and Staphylococcus aureus) and 
gram negative (Escherichia coli, Serratia marcescens, Klebsiella pneumoniae) bacteria has 
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been estimated and presented in Figure 2. Zone of inhibition was observed for both gram 
positive and gram negative bacteria. It indicates bactericidal activity of CdS QDs against 
Serratia marcescens followed by Staphylococcus aureus, Klebsiella pneumoniae, 
Streptococcus pyogens and Escherichia coli. In further analysis, the antibacterial activity found 
at Serratia marcescens implies clear zone and the size of the zone relay on concentrations of 
CdS QDs (80, 120, 160 and 200 µg/mL). Over all, at higher concentration of CdS QDs 200 
µg/mL a clear zone with 21 mm diameter is observed for Serratia marcescens. In the case of 
K. pneumoniae and S. aureus, the zone diameter is found to be 18 mm and 20 mm diameter 
respectively. These significant results advocate that the CdS QDs performed as a promising 
antibacterial agent against both gram positive and negative bacteria. It is noteworthy to mention 
that the cell wall of the gram positive and gram negative bacteria consists of thick 
peptidoglycan layer and lipopolysaccharide layer, respectively, which provides strong 
protection wall from foreign species  penetration.56 Therefore, the observed antibacterial 
activity of CdS QDs might due to their low-dimension particle size (3-5 nm), which is able to 
penetrate and pass through the nanopores of the bacteria cell wall thus enhancing the broad 
spectrum of antibacterial activity against the virulent bacteria. 
 14 
 
 
 
 Figure 2.  CdS QDs against (a) Escherichia coli (b) Klebsiellapneumoniae (c) Streptococcus 
pyogens (d) Serratiamarcescens and (e) Staphylococcus aureus [Note: ampicillin (10µg) and 
streptomycin (10µg) were used as control in each measurement]. 
Hemolysis activity: Hemolysis of the blood is a major issue associated with foreign 
materials like implants while inserted in the human body.57 The red blood cells (RBC) 
will be hemolysed when in contact with water. Therefore, biocompatibility of plant 
extract derived CdS QDs is studied through investigating hemolytic activity in RBC 
cells. 
 15 
 
Figure 3. The hemolysis activity for different concentration CdS QDs [note: 
measurements recorded after 3 hours by UV spectrophotometer at 541 nm]. 
For this analysis, the water was added to the RBC cells and then the released 
haemoglobin was measured using optical spectrophotometer (100% hemolysis). The 
estimated percentage of hemolytic activity of RBC at various CdS QD concentrations is 
summarised in Figure 3. From Figure 3, it seems that the hemolysis rate of CdS QDs 
in RBC monotonically increased and relay on dose concentration. At higher 
concentration of 60 µg/mL, the hemolysis rate is found to be 1.83 ±0.20%. Singhal et 
al.58 suggested that foreign biomaterial exhibits below 5% hemolysis, which is 
permissible in therapeutic /biomedical applications. For more understanding, the optical 
images of RBC cells in associate with higher concentration of CdS QDs at 60 µg/mL is 
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as shown in Figure S4 (see supporting information) compared with control (in the 
absence of QDs). It further endorses that Camellia sinensis derived CdS QDs does not 
produce significant morphological changes in RBC cells compared to untreated cell (in 
the absence of QDs).  
 
Cytotoxicity analysis: cytotoxic effect of the synthesized CdS QDs, against A549 cell line was 
studied. MTT assay was used to assess the effect of CdS QDs on proliferation of A549 cell 
line. The percentage of cell viability for different CdS QDs concentrations were examined at 
24 h and compared with standard drug cisplatin (Figure 4). Figure 4 implies that inhibition of 
A549 cells are gradually increased with CdS QDs concentration and is comparable with 
standard drug cisplatin (14 µg/mL) in 24 h period.  
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Figure 4. Cytotoxicity effect of A549 cell line treated with green CdS QDs and standard 
drug cisplatin.    
Figure.5 Optical microscope images of cytotoxicity effect observed at A549 cell line (a) 
control [untreated]; and treated with CdS QDs (b) 10 µg/mL, (c) 25 µg/mL and (d) 50 µg/mL 
[noted that images of A549 cell line is recorded after 24 hours]. 
The enhanced cytotoxic effect by CdS may ascribe to chemical interaction between CdS and 
A549 cell bio-environment. Furthermore, to ensure the CdS QDs/ bio-environment interface, 
the phase contrast microscope images were recorded and are presented in Figure 5 (a) – (d). 
Compared to an untreated cell (Figure 5a), the CdS QDs treated cells (Figure 5b, 5c and 5d) 
showed significant morphological changes due to A549 cell shrinkage, loss of membrane 
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integrity, cytoplasmic condensation and also cell growth inhibition.59 The plausible reason for 
the degradation of the A549 cells might be due to chemical interaction between CdS QDs and 
A549 cell. Briefly, green synthesized CdS QDs particles could interact with the phosphorous 
moieties in DNA. Then DNA replication is inactivated leading to inhibition of enzyme 
functions which results in loss of cell viability, further it undergoes cell death through 
apoptosis.  
Fluorescence imaging analysis:  The observed apoptosis effect from Figure 5 raise the 
question on which cycle of A549 cells growth is inhibited by CdS QDs. Therefore, we 
examine the apoptotic cell inhibition at different stages using fluorescence imaging. 
 
 
 
Figure 6. Fluorescence microscopy images of AO/EtBr stained A549 cells (a) untreated 
(control) and; CdS QDs treated at different concentration (b) 10, (c) 25 and (d) 50 
µg/mL. Note that AO/EtBr images are recorded using laser light excitation at 460 nm.   
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Due to the fact that fluorescence imaging uses different dyes it may not precisely portrait 
the cell condition. For instance, the acridine orange (AO) is a promising dye material it 
can bind both viable and dead cells. But in the case of ethidium bromide (EtBr), it only 
binds with dead cells due to loss of membrane integrity. When both AO/EtBr staining 
used in CdS QDs treated A549 cells we can qualitatively distinguish the influence of 
CdS QDs. Figure 6 (b-d) illustrates CdS QDs treated A549 cells at different 
concentration 10, 25 and 50 µg/mL after 24 h of incubation. The untreated A549 cells 
(Figure 6a) showing green colour implies live cells. In the case of Figure 6b-d shows 
different colours such as yellow (24 µg/mL), red (48 µg/mL), and orange (96 µg/mL), 
corresponding to early apoptotic cells, necrotic cells and late apoptotic cells, 
respectively. Based on this analysis, it is understood that the apoptosis effect at A549 
cells is dependent on the CdS QDs concentration. The influence of CdS QDs on A549 
cells occurred for several reasons including a) changes in chromatin condensation, b) 
fragmented nuclei and c) membrane blebbing.60 These factors were verified using 
another dye, DAPI, through a DAPI stain test (See supporting information Figure S6).  
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Figure 7. (a) Absorption and (b) fluorescence emission spectra (λexc= 410 nm) of Camellia 
sinensis derived Green CdS Quantum Dots in ethanol at different concentrations at room 
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temperature. (c) Absorbance at 410, 435, 500, 535, 600 and 635 nm and (d) fluorescence 
emission intensity at 670 nm as a function of the concentration. Absorbance spectra were 
smoothed (thick line) using the Savitzky-Golay method (22 points) but original are also plotted 
(thin line). 
It is noteworthy to discuss the unprecedented intracellular fluorescence images of the CdS 
QD treated A549 cells. Though these CdS QDs are not covered with any additional shell layer 
(ZnS, CdTe) they show high brightness and contrast images compared to recent articles on 
A549 cell tracking.61 Further analysis of the fluorescence properties of Camellia sinensis 
derived CdS QDs could explain why these CdS QDs produce effective intracellular 
fluorescence intensity. The absorption and fluorescence spectra of CdS QDs are presented in 
Figure 7 (a) - (d), respectively.  
 Figure 7 (a) shows the optical absorption spectra recorded at different wavelength. The 
strong optical absorbance peak observed around ~410-420 nm indicates the band edge of CdS 
QDs. Further recording optical absorbance quantity at different monochromatic wavelength 
(Figure 7 (b)) is clearly infers that CdS QDs have high optical absorbance at 410 nm. This is 
corresponding to 3.03 eV band gap energy. This implies that Camellia sinensis derived CdS 
QDs result ~0.53 eV higher than that of bulk CdS band gap energy (~2.4 eV) due to quantum 
confinement effect.62-63 The optical absorbance of CdS QDs increases with QD concentration 
(Figure 7c). From Figure 7 (d), the observed fluorescence emission ~670 nm is gradually 
enhanced with CdS QDs concentration. This enhanced fluorescence emission is responsible for 
the high contrast fluorescence bioimaging results obtained at Figure 6 (b)-(c).  
 
Cell cycle analysis: Optical (Figure 5) and florescence microscopy (figure 6) demonstrate A549 
cell death with CdS QDs treatment, thus the underlying mechanism of CdS QDs in arresting 
the cell cycle of A549 cells should be understood. In this view, the fluorescence-activated cell 
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sorting (FACS) analysis is a promising technique to exclusively evaluate the DNA content in 
different phases such as Go/G1, S and G2/M. During the G1 phase, DNA content within the 
cell. In S phase DNA replication will takes place and G2/M phase cells are divided into two 
daughter cells. The representative images of DNA flow cytometry is presented in Figure 8.  
Figure 8 (a-d) depicts the DNA count in untreated and CdS QDs treated A549 cells measured 
at 24 h incubation. The cell death rate results can be easily accounted from Figure 8. 
Comparing the DNA count in Go/G1, S and G2/M phases, S phase showed striking A549 cells 
death rate. The quantitative results are summarised in Figure S6. For S phase, the DNA count 
in untreated A549 cell was of 31.78% and gradually diminished to 14.98 under CdS QDs 
treatment (50 µg/mL). The similar DNA count degradation tendency is observed in G2M 
phase.  This apoptosis effect is the reason for noticing A549 cell death in Figure 5(c-d) which 
clearly explains the key role of CdS QDs interaction with A549 cell. 
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Figure 8. DNA flow cytometry of A549 cells recorded at 24 h incubation (a) control 
(untreated); and treated with CdS QDs (b) 10, (c) 25 and (d) 50 µg/mL. 
Furthermore, it is cross verified that the apoptosis effect occurred at the S stage, through flow 
cytometry using Annexin – FITC/ PI dual fluorescence staining. The representative flow 
cytometry Annexin – FITC/ PI dual fluorescence images is presented in Figure 9 (a-d). The 
early apoptotic cells will bind with Annexin. In the case of dead and late apoptotic cells are 
binds with both Annexin – FTIC and PI staining.64 The percentage of apoptotic cells is higher 
at CdS QDs treated A549 cells compared to untreated cells (Figure 9a). The estimated cells 
from Figure 9 (a-d) are compared in Figure S7. The overall results explain that early and late 
apoptotic cells are CdS QDs dose dependence increased from 28.05, 51.85 and 77.0% 
compared to control cells. As is explained earlier, the cell cycle arrest might be induced by 
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green synthesized CdS QDs, that have entered into the nucleus wall through the pores and 
interacting with the DNA. 65 
 
Figure 9. The apoptotic cell death in A549 cells analysed by flow cytometry using Annexin –
FITC/PI staining (a) control (untreated) and; CdS QDs (b) 10 (c) 25 and (d) 50 µg/mL. Note 
that the fluorescence intensity of Annexin – FITC/PI stained apoptotic cells expressed at the 
top and bottom right quadrants are in late and early apoptosis, respectively. 
As Figure 8 illustrates, DNA count ratio of A549 cells degraded in S and G2M phase, the 
major effect of apoptosis occurred in S phase and is undoubtedly explained in Figure 9. 
Therefore, we can conclude that plant extract mediated CdS QDs induced cell cycle arrest and 
has occurred at S phase. The effective bioimaging and apoptosis effect exists at CdS QDs 
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treated A549 cells strongly advocate that Camellia sinensis extract mediated QDs are futuristic 
in simultaneous bioimaging and therapeutic applications. In particular, examining these CdS 
QDs at in vivo condition will facilitate the cytotoxic effect in real-time bio-environment. 
Surprisingly, these green CdS QDs treated with healthy RBC cells do not show any 
morphological changes. These results endorse the biocompatibility nature of CdS QDs and 
encourage further in-vivo applications. Recent reviews state that cytotoxicity of Cd based QDs 
are less at in vivo condition compared to in vitro.66-68 Because, heavy-metal release and 
generation of reactive oxygen species will enhance the cytotoxicity at in vitro. In this condition, 
QDs may interact directly with blood components. In addition, QDs formulation is differ with 
synthesis protocol, size, surface chemistry.69 Therefore, a careful in vivo examination will be 
helpful in further standardising these green CdS QDs in cancer cell imaging and treatment. 
From a materials point of view, the influence of plant extract concentration on CdS particle 
size through surface passivation with appropriate biomolecules43, 70 will also promote this QDs 
in wide range of biological activity based applications.  
Conclusions 
In this work, for the first time, biological activity of Camellia sinensis extract mediated CdS 
quantum dots is demonstrated. The organic moieties such as polyphenol and protiens presence 
in the plant extract play a key role in stabilizing highly homogeneous CdS spherical 
nanoparticles ranging from 3 to 5 nm. Owing to the high florescence emission and quantum 
confinement effect results green CdS QDs are producing effective intracellular fluorescence 
cell tracking at A549 lung cancer cell. Furthermore, these low dimensional CdS QDs penetrate 
into nanopores of A549 cells and degrade the cell (cell death). The flow cytometry results 
confirm that Camellia sinensis extract mediated CdS quantum dots are highly reactive and 
stable in bioenvironment. The flow cytometry analysis confirms that CdS QDs arrested S phase 
of A549 cells. The experimental results suggest the Camellia sinensis extract mediated CdS 
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QDs are promising low dimensional biomaterial for wide range of biomedical applications 
(antibacterial, bioimaging and therapeutic). Interestingly, the Camellia sinensis extract will be 
obtained from not only fresh leaves, also mother leaves can be used which reduce the overall 
synthesis cost compare to conventional chemical stabilizers.  Further investigating the 
influence of Camellia sinensis extract concentration on CdS QDs size, CdS QDs/cell interfaces 
will be further interest for transforming green CdS QDs towards in vivo based applications. 
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